Ready, set, jet!By Anna KocharianWith the holidays quickly approaching, travel plans are surely materializing. Regardless of ...
Leerink Partners analyst Lili (Aurélie) Nsongo has reiterated their bullish stance on VYGR stock, giving a Buy rating yesterday.
Analyst Jack Allen of Robert W. Baird maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report), retaining the price target of $18.00. Jack Allen’s rating is based on several promising ...